Back to overview

3-year Industrial Postdoc Fellowship awarded to Lluís Riera-Ponsatí

This grant from the Innovation Fund Denmark (IFD) will help us in further establishing our drug discovery pipeline, aimed at developing disease-modifying RNA Therapies for Parkinson's Disease at NEUmiRNA, in collaboration with Aalborg University and the Center for RNA Medicine (CRM).
Funding
Awards
12.6.2025
Neumirna Receives 2024 CURE Epilepsy Catalyst Award
$250,000 in funding to support biomarker research and development of RNA therapy for drug-resistant epilepsy
Read full article
Awards
Funding
11.6.2025
Neumirna Receives 2025 Epilepsy Foundation Shark Tank Investment
$200,000 award supports Neumirna’s RNA-based approach to innovation in epilepsy treatment
Read full article
Development
8.5.2025
Neumirna Strengthens Board with Andreas Wallnöfer as Independent Board Member
Neumirna Therapeutics has named Andreas Wallnöfer as an independent member of its Board of Directors.
Read full article